Appointment booking for Dr. Michael Schilawski, OD is currently not available.Dr. Michael Schilawski, OD has not yet fully activated their profile on DiabetesIQ.
Dr. Michael Schilawski, OD (he/him) is a Optometrist in Wilmington, NC with over 14 years of experience. What is your opinion of Dr. Michael Schilawski, OD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 14 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Michael Schilawski, OD has received over $5,793 which includes payments from the following companies:
$2,605.68 from Alcon Laboratories Inc
$634.27 from Bausch & Lomb, a division of Bausch Health US, LLC
$556.32 from Johnson & Johnson Vision Care, Inc.
$535.36 from CooperVision Inc.
$371.02 from Allergan Inc.
$285.63 from Valeant Pharmaceuticals North America LLC
$284.93 from Shire North American Group Inc
$141.75 from Bausch and Lomb Inc.
$111.57 from Sun Pharmaceutical Industries Inc.
$101.59 from Johnson & Johnson Surgical Vision, Inc.
$48.03 from Novartis Pharmaceuticals Corporation
$40.81 from Alcon Research Ltd
$37.86 from OPTOS, INC.
$14.15 from GLAUKOS CORPORATION
$12.34 from Novabay Pharmaceuticals, Inc.
$11.78 from Aerie Pharmaceuticals, Inc.
Payments received by Dr. Michael Schilawski, OD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!